Metabolic Dysfunction-Associated Steatotic Liver Disease: Heterogeneity of Its Pathophysiology and Its Relationship with Type 2 Diabetes Mellitus
People with MASLD are at increased risk of developing hepatic decompensation and hepatocellular carcinoma, and are also at increased risk of type 2 diabetes mellitus, cardiovascular disease, and chronic kidney disease.